Fatigue News and Research RSS Feed - Fatigue News and Research

Timely diagnosis and treatment important to combat juvenile arthritis

Timely diagnosis and treatment important to combat juvenile arthritis

Most people associate arthritis with aging, but the fact is, one in 1,000 children is diagnosed with juvenile arthritis. [More]
Trinidad & Tobago Ministry of Health approves hepatitis C drug telaprevir

Trinidad & Tobago Ministry of Health approves hepatitis C drug telaprevir

The Chemistry, Food & Drugs Division of the Trinidad & Tobago Ministry of Health approved the introduction of Telaprevir to the market, an innovative therapy that significantly increases the cure rate from Hepatitis C, and it is indicated for patients infected with the genotype 1 virus. Telaprevir is available in Trinidad under the trade brand INCIVO®. [More]
Phase 3 trial: NEXAVAR tablets fail to meet primary endpoint in HER2-negative breast cancer patients

Phase 3 trial: NEXAVAR tablets fail to meet primary endpoint in HER2-negative breast cancer patients

Bayer HealthCare and Onyx Pharmaceuticals Inc., an Amgen subsidiary, today announced that an investigational Phase 3 trial of NEXAVAR (sorafenib) tablets in patients with advanced breast cancer did not meet its primary endpoint of improving progression-free survival (PFS). [More]
Obese people have low endurance, experience excess fatigue in workplace

Obese people have low endurance, experience excess fatigue in workplace

Workplaces may need to consider innovative meethods to prevent fatigue from developing in employees who are obese. Based on results from a new study published in the Journal of Occupational and Environmental Hygiene, workers who are obese may have significantly shorter endurance times when perfroming workplace tasks, compared with non-obese counterparts. [More]
Zydelig gets FDA approval for treatment of patients with three types of blood cancers

Zydelig gets FDA approval for treatment of patients with three types of blood cancers

The U.S. Food and Drug Administration today approved Zydelig (idelalisib) to treat patients with three types of blood cancers. [More]
Scientist develops highly accurate device for diagnosing fatal lung disease

Scientist develops highly accurate device for diagnosing fatal lung disease

A scientist from the University of Exeter has developed a simple, cheap and highly accurate device for diagnosing a frequently fatal lung disease which attacks immune deficient individuals such as cancer patients and bone marrow transplant recipients. [More]
University of Leicester receives funding from two Masonic charities for heart study

University of Leicester receives funding from two Masonic charities for heart study

A University of Leicester research project has received vital philanthropic funding for the second year from two Masonic charities. [More]
Pilot study shows that anti-cancer drug can activate hidden HIV

Pilot study shows that anti-cancer drug can activate hidden HIV

A pilot study by HIV researchers from Aarhus University and Aarhus University Hospital in Denmark has shown that an anti-cancer drug can activate hidden HIV. [More]
Parents severely underestimate time children spend on digital devices

Parents severely underestimate time children spend on digital devices

According to the American Optometric Association (AOA), parents severely underestimate the time their children spend on digital devices. An AOA survey reports that 83 percent of children between the ages of 10 and 17 estimate they use an electronic device for three or more hours each day. [More]

NuAire's Laminar Airflow Workstations create bacteria-free, clean air environment

NuAire's AireGard ES NU-201 Table Top and NU-301 Console Horizontal Laminar Airflow Hoods provide a HEPA filtered clean work area that is ideal for operations requiring a particle-free, bacteria-free, clean air environment. [More]

NuAire Biosafety Cabinets offer proper ergonomics and improve laboratory safety

NuAire LabGard ES and CellGard ES (Energy Saver) brand of Class II Biological Safety Cabinets offer the proper ergonomics, reduce energy, and improve laboratory safety. [More]
α1-adrenoceptor blockade improves nocturia and sleep quality

α1-adrenoceptor blockade improves nocturia and sleep quality

Treatment with an α1-adrenoceptor antagonist drug is associated with significant improvements in nocturia, sleep quality and lower urinary tract symptoms in women with voiding symptoms, study findings show. [More]
Rigel initiates Phase 3 clinical program for fostamatinib in patients with ITP

Rigel initiates Phase 3 clinical program for fostamatinib in patients with ITP

Rigel Pharmaceuticals, Inc. today announced the initiation of a Phase 3 clinical program for its oral SYK inhibitor, fostamatinib, in patients with ITP (immune thrombocytopenic purpura). [More]

Hydroxychloroquine treatment not effective for primary Sjögren syndrome

Among patients with the systemic autoimmune disease primary Sjögren syndrome, use of hydroxychloroquine, the most frequently prescribed treatment for the disorder, did not improve symptoms during 24 weeks of treatment compared with placebo, according to a study in the July 16 issue of JAMA. [More]
CGP partners with Leader Prospects to serve employees of Indian companies

CGP partners with Leader Prospects to serve employees of Indian companies

Chestnut Global Partners (www.chestnutglobalpartners.org), a provider of culturally-aware employee assistance and wellness programs to companies worldwide, today announced that it has partnered with Leader Prospects, an HR and work/life consulting company based in India, to form CGP India (CGPI). [More]
Medac Pharma's Rasuvo injection gets FDA approval for RA, pJIA and psoriasis

Medac Pharma's Rasuvo injection gets FDA approval for RA, pJIA and psoriasis

Medac Pharma, Inc., a privately held pharmaceutical company focused on the development of new molecules and improving the effectiveness of existing medicines, announced that the U.S. Food and Drug Administration has approved Rasuvo, a subcutaneous injectable methotrexate (MTX) therapy delivered in an auto-injector for rheumatoid arthritis (RA), polyarticular-course juvenile idiopathic arthritis (pJIA) and psoriasis. [More]

Counselling and guidance techniques may not be appropriate for many African countries

Counselling and guidance techniques developed in the Western world may not be appropriate for many African countries, where cultural influences, government policies and the availability of resources can have significant implications for service delivery. [More]
Letrozole drug results in higher birth rates in women with PCOS

Letrozole drug results in higher birth rates in women with PCOS

The drug letrozole results in higher birth rates in women with polycystic ovary syndrome (PCOS) than the current preferred infertility treatment drug, according to a nationwide study led by Penn State College of Medicine researchers. [More]
FDA approves Protein Sciences' strain change amendment for Flublok influenza vaccine

FDA approves Protein Sciences' strain change amendment for Flublok influenza vaccine

Protein Sciences Corporation announced today that the FDA has approved the Company's strain change amendment for its seasonal influenza vaccine, Flublok. [More]
Doctors offer new minimally invasive system to treat patients with narrowed, failing aortic heart

Doctors offer new minimally invasive system to treat patients with narrowed, failing aortic heart

Doctors at the Orlando Health Heart Institute are offering a new minimally invasive system to treat patients with narrowed, failing aortic heart valves who are considered to be at high risk to undergo surgery. Orlando Health is the only hospital in Orlando currently offering the Medtronic CoreValve® System. [More]